Related references
Note: Only part of the references are listed.Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019
Pankaj Bansal et al.
ANNALS OF MEDICINE (2021)
Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19
Oriol Mitja et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188
Gordon J. Lockbaum et al.
VIRUSES-BASEL (2021)
Remdesivir and systemic corticosteroids for the treatment of COVID-19: A Bayesian re-analysis
Todd C. Lee et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Dami A. Collier et al.
NATURE (2021)
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Pengfei Wang et al.
NATURE (2021)
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Zijun Wang et al.
NATURE (2021)
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
Noa Dagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera
Alexander Muik et al.
SCIENCE (2021)
The emergence of new strains of SARS-CoV-2. What does it mean for COVID-19 vaccines?
Md Kamal Hossain et al.
EXPERT REVIEW OF VACCINES (2021)
CORONAVIRUS VARIANTS ARE SPREADING IN INDIA - WHAT SCIENTISTS KNOW SO FAR
Gayathri Vaidyanathan
NATURE (2021)
Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine
Matan Levine-Tiefenbrun et al.
NATURE MEDICINE (2021)
From Vaccine Nationalism to Vaccine Equity - Finding a Path Forward
Ingrid T. Katz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease
Sebastian Guenther et al.
SCIENCE (2021)
A global database of COVID-19 vaccinations
Edouard Mathieu et al.
NATURE HUMAN BEHAVIOUR (2021)
Possible Link between Higher Transmissibility of Alpha, Kappa and Delta Variants of SARS-CoV-2 and Increased Structural Stability of Its Spike Protein and hACE2 Affinity
Vipul Kumar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
SARS-CoV-2 variants of concern are emerging in India
Jasdeep Singh et al.
NATURE MEDICINE (2021)
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination
Markus Hoffmann et al.
CELL REPORTS (2021)
COVID-19 Treatment Guidelines: Do They Really Reflect Best Medical Practices to Manage the Pandemic?
Feras Jirjees et al.
INFECTIOUS DISEASE REPORTS (2021)
Neutralizing monoclonal antibodies for treatment of COVID-19
Peter C. Taylor et al.
NATURE REVIEWS IMMUNOLOGY (2021)
An interactive web-based dashboard to track COVID-19 in real time
Ensheng Dong et al.
LANCET INFECTIOUS DISEASES (2020)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
SARS-CoV-2 entry in host cells-multiple targets for treatment and prevention
Ismail Sami Mahmoud et al.
BIOCHIMIE (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
David E. Gordon et al.
NATURE (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Jia Liu et al.
CELL DISCOVERY (2020)
Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
Georgia Ragia et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Bette Korber et al.
CELL (2020)
Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities
Siyu Xiu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach
Ahmad Abu Turab Naqvi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2
Markus Hoffmann et al.
NATURE (2020)
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
Xiangyang Chi et al.
SCIENCE (2020)
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19 A Randomized Clinical Trial
Christoph D. Spinner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States
Jennifer Harcourt et al.
EMERGING INFECTIOUS DISEASES (2020)
Covalent Versus Non-covalent Enzyme Inhibition: Which Route Should We Take? A Justification of the Good and Bad from Molecular Modelling Perspective
Aimen Aljoundi et al.
PROTEIN JOURNAL (2020)
Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: a review on the mode of action and emerging trial data
Aurore B. Hounkpatin et al.
INFECTION AND DRUG RESISTANCE (2019)
Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria - United States, 2019
Julia C. Haston et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)
Limited proteolysis as a tool to probe the tertiary conformation of dysferlin and structural consequences of patient missense variant L344P
Natalie Woolger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum
Roland Boettger et al.
PLOS ONE (2017)
An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
Thanigaimalai Pillaiyar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Disrupting the Constitutive, Homodimeric Protein-Protein Interface in CK2β Using a Biophysical Fragment-Based Approach
Wei-Guang Seetoh et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date
Yehenew A. Ebstie et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Killing the hypnozoite - drug discovery approaches to prevent relapse in Plasmodium vivax
Brice Campo et al.
PATHOGENS AND GLOBAL HEALTH (2015)
A structural view of the inactivation of the SARS coronavirus main proteinase by benzotriazole esters
Koen H. G. Verschueren et al.
CHEMISTRY & BIOLOGY (2008)
Coronaviridae and SARS-associated coronavirus strain HSR1
E Vicenzi et al.
EMERGING INFECTIOUS DISEASES (2004)
Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery
MC Lo et al.
ANALYTICAL BIOCHEMISTRY (2004)
SARS coronavirus induces apoptosis in Vero E6 cells
HM Yan et al.
JOURNAL OF MEDICAL VIROLOGY (2004)
The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor
HT Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs
K Anand et al.
SCIENCE (2003)
Size-distribution analysis of proteins by analytical ultracentrifugation: Strategies and application to model systems
P Schuck et al.
BIOPHYSICAL JOURNAL (2002)
Conservation of substrate specificities among coronavirus main proteases
A Hegyi et al.
JOURNAL OF GENERAL VIROLOGY (2002)
High-density miniaturized thermal shift assays as a general strategy for drug discovery
MW Pantoliano et al.
JOURNAL OF BIOMOLECULAR SCREENING (2001)
Share Paper
